Recent advances in central cardiovascular control: Sex, ROS, gas and inflammation

F1000Research

Volumn 5, Issue , 2016, Pages 1-

  Ferguson, Alastair V ^a   Smith, Pauline M ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ESTRADIOL; ESTROGEN; GASOTRANSMITTER; HYDROGEN SULFIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; RELAXIN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR HOMEOSTASIS; CELL ACTIVATION; DENDRITIC CELL; DISEASE ASSOCIATION; GENDER; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPERTENSION; IMMUNOREGULATION; INFLAMMATION; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; SIGNAL TRANSDUCTION;

EID: 84969651456     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.7987.1     Document Type: Article

References (123)

1. World Health Organization: Causes of Death 2008. Reference Source
2. Lim SS Vos T Flaxman AD: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224-60. 23245609 10.1016/S0140-6736(12)61766-8 4156511
3. World Health Organization. Global status report on noncommunicable diseases 2011.
4. DiBona GF: Sympathetic nervous system and hypertension. Hypertension. 2013;61(3):556-60. 23357181 10.1161/HYPERTENSIONAHA.111.00633
5. Guyenet PG: The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7(5):335-46. 16760914 10.1038/nrn1902
6. Parati G Esler M: The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J. 2012;33(9):1058-66. 22507981 10.1093/eurheartj/ehs041
7. Leenen FH: Actions of circulating angiotensin II and aldosterone in the brain contributing to hypertension. Am J Hypertens. 2014;27(8):1024-32. 24742639 10.1093/ajh/hpu066
8. Moon JY: Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension. Electrolyte Blood Press. 2013;11(2):41-5. 24627703 10.5049/EBP.2013.11.2.41 3950224
9. White FN Grollman A: Autoimmune Factors Associated With Infarction Of The Kidney. Nephron. 1964;1(2):93-102. 14248727 10.1159/000179322
10. Chae CU Lee RT Rifai N: Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38(3):399-403. 11566912 10.1161/01.HYP.38.3.399
11. Engström G Janzon L Berglund G: Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol. 2002;22(12):2054-8. 12482834 10.1161/01.ATV.0000041842.43905.F3
12. Vinh A Chen W Blinder Y: Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation. 2010;122(24):2529-37. 21126972 10.1161/CIRCULATIONAHA.109.930446 3064430 F1000 Recommendation
13. Xiao L Kirabo A Wu J: Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension. Circ Res. 2015;117(6):547-57. 26156232 10.1161/CIRCRESAHA.115.306010 4629828 F1000 Recommendation
14. Boesen EI Williams DL Pollock JS: Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats. Clin Exp Pharmacol Physiol. 2010;37(10):1016-22. 20626757 10.1111/j.1440-1681.2010.05428.x 3612979
15. Muller DN Shagdarsuren E Park JK: Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol. 2002;161(5):1679-93. 12414515 10.1016/S0002-9440(10)64445-8 1850776
16. Rodríguez-Iturbe B Pons H Quiroz Y: Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int. 2001;59(6):2222-32. 11380825 10.1046/j.1523-1755.2001.00737.x
17. Rodríguez-Iturbe B Quiroz Y Nava M: Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol. 2002;282(2):F191-201. 11788432 10.1152/ajprenal.0197.2001
18. Bomfim GF Dos Santos RA Oliveira MA: Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. Clin Sci (Lond). 2012;122(11):535-43. 22233532 10.1042/CS20110523 4004345 F1000 Recommendation
19. Sollinger D Eißler R Lorenz S: Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension. Cardiovasc Res. 2014;101(3):464-72. 24302630 10.1093/cvr/cvt265 F1000 Recommendation
20. Guzik TJ Hoch NE Brown KA: Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med. 2007;204(10):2449-60. 17875676 10.1084/jem.20070657 2118469 F1000 Recommendation
21. Hoch NE Guzik TJ Chen W: Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol. 2009;296(2):R208-16. 19073907 10.1152/ajpregu.90521.2008 2643984
22. Bautista LE Vera LM Arenas IA: Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens. 2005;19(2):149-54. 15361891 10.1038/sj.jhh.1001785
23. Chamarthi B Williams GH Ricchiuti V: Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans. Am J Hypertens. 2011;24(10):1143-8. 21716327 10.1038/ajh.2011.113 3807212
24. Madhur MS Lob HE McCann LA: Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension. 2010;55(2):500-7. 3807212 10.1161/HYPERTENSIONAHA.109.145094 2819301 F1000 Recommendation
25. Crowley SD Song Y Lin EE: Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2010;298(4):R1089-97. 20147609 10.1152/ajpregu.00373.2009 4422347
26. Sriramula S Cardinale JP Francis J: Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLoS One. 2013;8(5):e63847. 23691105 10.1371/journal.pone.0063847 3655013
27. Lee DL Sturgis LC Labazi H: Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am J Physiol Heart Circ Physiol. 2006;290(3):H935-40. 16284237 10.1152/ajpheart.00708.2005
28. Siddiqui AH Irani RA Zhang W: Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia. Hypertension. 2013;61(2):472-9. 23283357 10.1161/HYPERTENSIONAHA.111.00157 4131732
29. Wallukat G Homuth V Fischer T: Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103(7):945-52. 10194466 10.1172/JCI4106 408252
30. Liao Y Wei YM Wang M: Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension. Hypertens Res. 2002;25(4):641-6. 12358154 10.1291/hypres.25.641
31. Zhu F Sun YX Liao YH: Agonistic AT 1 receptor autoantibody increases in serum of patients with refractory hypertension and improves Ca 2+ mobilization in cultured rat vascular smooth muscle cells. Cell Mol Immunol. 2008;5(3):209-17. 18582403 10.1038/cmi.2008.26 4651272
32. Dragun D Müller DN Bräsen JH: Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med. 2005;352(6):558-69. 15703421 10.1056/NEJMoa035717 F1000 Recommendation
33. Waki H Hendy EB Hindmarch CC: Excessive leukotriene B4 in nucleus tractus solitarii is prohypertensive in spontaneously hypertensive rats. Hypertension. 2013;61(1):194-201. 23172924 10.1161/HYPERTENSIONAHA.112.192252 4506640
34. Gouraud SS Waki H Bhuiyan ME: Down-regulation of chemokine Ccl5 gene expression in the NTS of SHR may be pro-hypertensive. J Hypertens. 2011;29(4):732-40. 21358418 10.1097/HJH.0b013e328344224d
35. Waki H Gouraud SS Maeda M: Contributions of vascular inflammation in the brainstem for neurogenic hypertension. Respir Physiol Neurobiol. 2011;178(3):422-8. 21601658 10.1016/j.resp.2011.05.004
36. Gouraud SS Takagishi M Kohsaka A: Altered neurotrophic factors' expression profiles in the nucleus of the solitary tract of spontaneously hypertensive rats. Acta Physiol (Oxf). 2016;216(3):346-57. 26485190 10.1111/apha.12618 F1000 Recommendation
37. Takagishi M Waki H Bhuiyan ME: IL-6 microinjected in the nucleus tractus solitarii attenuates cardiac baroreceptor reflex function in rats. Am J Physiol Regul Integr Comp Physiol. 2010;298(1):R183-90. 19907006 10.1152/ajpregu.00176.2009
38. Wu KLH Chan SHH Chan JY: Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation. J Neuroinflammation. 2012;9:212. 22958438 10.1186/1742-2094-9-212 3462714 F1000 Recommendation
39. Buggy J Fink GD Johnson AK: Prevention of the development of renal hypertension by anteroventral third ventricular tissue lesions. Circ Res. 1977;40(5 Suppl 1):I110-7. 858173
40. Marvar PJ Thabet SR Guzik TJ: Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res. 2010;107(2):263-70. 20558826 10.1161/CIRCRESAHA.110.217299 2921936 F1000 Recommendation
41. Desson SE Ferguson AV: Interleukin 1beta modulates rat subfornical organ neurons as a result of activation of a non-selective cationic conductance. J Physiol. 2003;550(Pt 1):113-22. 12879863 10.1113/jphysiol.2003.041210 2343005
42. Wei SG Yu Y Zhang ZH: Proinflammatory cytokines upregulate sympathoexcitatory mechanisms in the subfornical organ of the rat. Hypertension. 2015;65(5):1126-33. 25776070 10.1161/HYPERTENSIONAHA.114.05112 4393369 F1000 Recommendation
43. Sriramula S Cardinale JP Lazartigues E: ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res. 2011;92(3):401-8. 21952934 10.1093/cvr/cvr242 3286198
44. Yu XJ Zhang DM Jia LL: Inhibition of NF-κB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress. Toxicol Appl Pharmacol. 2015;284(3):315-22. 25759242 10.1016/j.taap.2015.02.023 F1000 Recommendation
45. Zhang M Qin DN Suo YP: Endogenous hydrogen peroxide in the hypothalamic paraventricular nucleus regulates neurohormonal excitation in high salt-induced hypertension. Toxicol Lett. 2015;235(3):206-15. 25891026 10.1016/j.toxlet.2015.04.008 F1000 Recommendation
46. Cutler JA Sorlie PD Wolz M: Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52(5):818-27. 18852389 10.1161/HYPERTENSIONAHA.108.113357 F1000 Recommendation
47. Hart EC Charkoudian N: Sympathetic neural regulation of blood pressure: influences of sex and aging. Physiology (Bethesda). 2014;29(1):8-15. 24382867 10.1152/physiol.00031.2013
48. Iams SG Wexler BC: Inhibition of the development of spontaneous hypertension in SH rats by gonadectomy or estradiol. J Lab Clin Med. 1979;94(4):608-16. 225399
49. Sasaki T Ohno Y Otsuka K: Oestrogen attenuates the increases in blood pressure and platelet aggregation in ovariectomized and salt-loaded Dahl salt-sensitive rats. J Hypertens. 2000;18(7):911-7. 10930189 10.1097/00004872-200018070-00013
50. Fogari R Preti P Zoppi A: Serum testosterone levels and arterial blood pressure in the elderly. Hypertens Res. 2005;28(8):625-30. 16392765 10.1291/hypres.28.625
51. Svartberg J von Mühlen D Schirmer H: Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study. Eur J Endocrinol. 2004;150(1):65-71. 14713281 10.1530/eje.0.1500065
52. Bhattacharya RK Khera M Blick G: Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocr Disord. 2011;11:18. 22044661 10.1186/1472-6823-11-18 3217857
53. Li JY Zhu JC Dou JT: Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study. Aging Male. 2002;5(1):47-51. 12040975 10.1080/tam.5.1.47.51
54. Dahl LK Knudsen KD Ohanian EV: Role of the gonads in hypertension-prone rats. J Exp Med. 1975;142(3):748-59. 1165474 2189927
55. Ouchi Y Share L Crofton JT: Sex difference in the development of deoxycorticosterone-salt hypertension in the rat. Hypertension. 1987;9(2):172-7. 3818014 10.1161/01.HYP.9.2.172
56. Chen YF Naftilan AJ Oparil S: Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension. 1992;19(5):456-63. 1568764 10.1161/01.HYP.19.5.456
57. Laflamme N Nappi RE Drolet G: Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J Neurobiol. 1998;36(3):357-78. 9733072 10.1002/(SICI)1097-4695(19980905)36:3<357::AID-NEU5>3.0.CO;2-V
58. Rosas-Arellano MP Solano-Flores LP Ciriello J: Co-localization of estrogen and angiotensin receptors within subfornical organ neurons. Brain Res. 1999;837(1-2):254-62. 10434010 10.1016/S0006-8993(99)01672-8
59. Simerly RB Chang C Muramatsu M: Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol. 1990;294(1):76-95. 2324335 10.1002/cne.902940107
60. Somponpun SJ Johnson AK Beltz T: Estrogen receptor-alpha expression in osmosensitive elements of the lamina terminalis: regulation by hypertonicity. Am J Physiol Regul Integr Comp Physiol. 2004;287(3):R661-9. 15142833 10.1152/ajpregu.00136.2004
61. Spary EJ Maqbool A Batten TF: Oestrogen receptors in the central nervous system and evidence for their role in the control of cardiovascular function. J Chem Neuroanat. 2009;38(3):185-96. 19505570 10.1016/j.jchemneu.2009.05.008
62. Xue B Zhao Y Johnson AK: Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species. Am J Physiol Heart Circ Physiol. 2008;295(3):H1025-H1032. 18599599 10.1152/ajpheart.00021.2008 2544478
63. Xue B Badaue-Passos D Jr Guo F: Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone/NaCl-induced hypertension. Am J Physiol Heart Circ Physiol. 2009;296(5):H1577-85. 19270192 10.1152/ajpheart.01255.2008 2685359
64. Xue B Zhang Z Beltz TG: Estrogen receptor-β in the paraventricular nucleus and rostroventrolateral medulla plays an essential protective role in aldosterone/salt-induced hypertension in female rats. Hypertension. 2013;61(6):1255-62. 23608653 10.1161/HYPERTENSIONAHA.111.00903 3893074
65. Li Z Hay M: 17-beta-estradiol modulation of area postrema potassium currents. J Neurophysiol. 2000;84(3):1385-91. 10980011
66. Ciriello J Roder S: 17β-Estradiol alters the response of subfornical organ neurons that project to supraoptic nucleus to plasma angiotensin II and hypernatremia. Brain Res. 2013;1526:54-64. 23830850 10.1016/j.brainres.2013.06.038
67. Pamidimukkala J Hay M: 17 beta-Estradiol inhibits angiotensin II activation of area postrema neurons. Am J Physiol Heart Circ Physiol. 2003;285(4):H1515-20. 12829428 10.1152/ajpheart.00174.2003
68. Xue B Zhang Z Beltz TG: Genetic knockdown of estrogen receptor-alpha in the subfornical organ augments ANG II-induced hypertension in female mice. Am J Physiol Regul Integr Comp Physiol. 2015;308(6):R507-16. 25552661 10.1152/ajpregu.00406.2014 4360069 F1000 Recommendation
69. Gingerich S Krukoff TL: Estrogen in the paraventricular nucleus attenuates L-glutamate-induced increases in mean arterial pressure through estrogen receptor beta and NO. Hypertension. 2006;48(6):1130-6. 17075034 10.1161/01.HYP.0000248754.67128.ff
70. Shih CD: Activation of estrogen receptor beta-dependent nitric oxide signaling mediates the hypotensive effects of estrogen in the rostral ventrolateral medulla of anesthetized rats. J Biomed Sci. 2009;16:60. 19583861 10.1186/1423-0127-16-60 2717931
71. St-Louis J Massicotte G: Chronic decrease of blood pressure by rat relaxin in spontaneously hypertensive rats. Life Sci. 1985;37(14):1351-7. 4046737 10.1016/0024-3205(85)90251-6
72. Ma S Shen P Burazin TC: Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [33P]-relaxin binding sites in rat brain: restricted somatic co-expression a clue to relaxin action? Neuroscience. 2006;141(1):329-44. 16725278 10.1016/j.neuroscience.2006.03.076 F1000 Recommendation
73. Mumford AD Parry LJ Summerlee AJ: Lesion of the subfornical organ affects the haemotensive response to centrally administered relaxin in anaesthetized rats. J Endocrinol. 1989;122(3):747-55. 2809482
74. Sun HJ Chen D Han Y: Relaxin in paraventricular nucleus contributes to sympathetic overdrive and hypertension via PI3K-Akt pathway. Neuropharmacology. 2016;103:247-56. 26746861 10.1016/j.neuropharm.2015.12.023 F1000 Recommendation
75. Stumpe KO Kolloch R Higuchi M: Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control. Lancet. 1977;2(8031):211-4. 69827 10.1016/S0140-6736(77)92832-X
76. Leaños-Miranda A Márquez-Acosta J Cárdenas-Mondragón GM: Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes. J Clin Endocrinol Metab. 2008;93(7):2492-9. 18460570 10.1210/jc.2008-0305
77. Oney T Bellmann O Kaulhausen H: Relationship between serum prolactin concentration, vascular angiotensin sensitivity and arterial blood pressure during third trimester pregnancy. Arch Gynecol Obstet. 1988;243(2):83-90. 3401043 10.1007/BF00932973
78. Zhang L Curhan GC Forman JP: Plasma prolactin level and risk of incident hypertension in postmenopausal women. J Hypertens. 2010;28(7):1400-5. 20453663 10.1097/HJH.0b013e328339f254 3139424 F1000 Recommendation
79. Georgiopoulos GA Stamatelopoulos KS Lambrinoudaki I: Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension. 2009;54(1):98-105. 19451414 10.1161/HYPERTENSIONAHA.109.132100 F1000 Recommendation
80. Bole-Feysot C Goffin V Edery M: Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998;19(3):225-68. 9626554 10.1210/edrv.19.3.0334
81. Patil MJ Henry MA Akopian AN: Prolactin receptor in regulation of neuronal excitability and channels. Channels (Austin). 2014;8(3):193-202. 24758841 10.4161/chan.28946 4203747
82. Brown RS Kokay IC Herbison AE: Distribution of prolactin-responsive neurons in the mouse forebrain. J Comp Neurol. 2010;518(1):92-102. 19882722 10.1002/cne.22208
83. Hindmarch C Fry M Yao ST: Microarray analysis of the transcriptome of the subfornical organ in the rat: regulation by fluid and food deprivation. Am J Physiol Regul Integr Comp Physiol. 2008;295(6):R1914-20. 18832082 10.1152/ajpregu.90560.2008
84. Durante W Johnson FK Johnson RA: Role of carbon monoxide in cardiovascular function. J Cell Mol Med. 2006;10(3):672-86. 16989727 10.1111/j.1582-4934.2006.tb00427.x
85. Zhao Y Vanhoutte PM Leung SW: Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci. 2015;129(2):83-94. 26499181 10.1016/j.jphs.2015.09.002
86. Abe K Kimura H: The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci. 1996;16(3):1066-71. 8558235
87. Hosoki R Matsuki N Kimura H: The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun. 1997;237(3):527-31. 9299397 10.1006/bbrc.1997.6878
88. Kuo SM Lea TC Stipanuk MH: Developmental pattern, tissue distribution, and subcellular distribution of cysteine: alpha-ketoglutarate aminotransferase and 3-mercaptopyruvate sulfurtransferase activities in the rat. Biol Neonate. 1983;43(1-2):23-32. 6573924
89. Benavides GA Squadrito GL Mills RW: Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A. 2007;104(46):17977-82. 17951430 10.1073/pnas.0705710104 2084282 F1000 Recommendation
90. Sun L Sun S Li Y: Potential biomarkers predicting risk of pulmonary hypertension in congenital heart disease: the role of homocysteine and hydrogen sulfide. Chin Med J (Engl). 2014;127(5):893-9. 24571884
91. Sun NL Xi Y Yang SN: [Plasma hydrogen sulfide and homocysteine levels in hypertensive patients with different blood pressure levels and complications]. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35(12):1145-8. 18341820
92. Wang C Han J Xiao L: Role of hydrogen sulfide in portal hypertension and esophagogastric junction vascular disease. World J Gastroenterol. 2014;20(4):1079-87. 24574782 10.3748/wjg.v20.i4.1079 3921533
93. Holwerda KM Bos EM Rajakumar A: Hydrogen sulfide producing enzymes in pregnancy and preeclampsia. Placenta. 2012;33(6):518-21. 22391326 10.1016/j.placenta.2012.02.014
94. Wang K Ahmad S Cai M: Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation. 2013;127(25):2514-22. 23704251 10.1161/CIRCULATIONAHA.113.001631
95. d'Emmanuele di Villa Bianca R Sorrentino R Coletta C: Hydrogen sulfide-induced dual vascular effect involves arachidonic acid cascade in rat mesenteric arterial bed. J Pharmacol Exp Ther. 2011;337(1):59-64. 21228064 10.1124/jpet.110.176016
96. Baragatti B Ciofini E Sodini D: Hydrogen sulfide in the mouse ductus arteriosus: a naturally occurring relaxant with potential EDHF function. Am J Physiol Heart Circ Physiol. 2013;304(7):H927-34. 23376828 10.1152/ajpheart.00718.2012
97. Martelli A Testai L Breschi MC: Vasorelaxation by hydrogen sulphide involves activation of K v7 potassium channels. Pharmacol Res. 2013;70(1):27-34. 23287425 10.1016/j.phrs.2012.12.005
98. Ariyaratnam P Loubani M Morice AH: Hydrogen sulphide vasodilates human pulmonary arteries: a possible role in pulmonary hypertension? Microvasc Res. 2013;90:135-7. 24035755 10.1016/j.mvr.2013.09.002
99. 2+ sparks. Am J Physiol Heart Circ Physiol. 2013;304(11):H1446-54. 23525712 10.1152/ajpheart.00506.2012 4073893
100. Zhao W Zhang J Lu Y: The vasorelaxant effect of H 2S as a novel endogenous gaseous K ATP channel opener. EMBO J. 2001;20(21):6008-16. 11689441 10.1093/emboj/20.21.6008 125693
101. Ahmad FU Sattar MA Rathore HA: Exogenous hydrogen sulfide (H 2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats. Ren Fail. 2012;34(2):203-10. 22229751 10.3109/0886022X.2011.643365
102. Ahmad FU Sattar MA Rathore HA: Hydrogen sulphide and tempol treatments improve the blood pressure and renal excretory responses in spontaneously hypertensive rats. Ren Fail. 2014;36(4):598-605. 24502512 10.3109/0886022X.2014.882218
103. Li L Whiteman M Guan YY: Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation. 2008;117(18):2351-60. 18443240 10.1161/CIRCULATIONAHA.107.753467
104. Yan H Du J Tang C: The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun. 2004;313(1):22-7. 14672692 10.1016/j.bbrc.2003.11.081
105. Yang G Wu L Jiang B: H 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science. 2008;322(5901):587-90. 18948540 10.1126/science.1162667 2749494 F1000 Recommendation
106. Ren YS Wu SY Wang XJ: Multiple hemodynamic effects of endogenous hydrogen sulfide on central nervous system in rats. Chin Med J (Engl). 2011;124(21):3468-75. 22340160 10.3760/cma.j.issn.0366-6999.2011.21.006
107. Guo Q Jin S Wang XL: Hydrogen sulfide in the rostral ventrolateral medulla inhibits sympathetic vasomotor tone through ATP-sensitive K + channels. J Pharmacol Exp Ther. 2011;338(2):458-65. 21558438 10.1124/jpet.111.180711
108. Gan XB Liu TY Xiong XQ: Hydrogen sulfide in paraventricular nucleus enhances sympathetic activity and cardiac sympathetic afferent reflex in chronic heart failure rats. PLoS One. 2012;7(11):e50102. 23166827 10.1371/journal.pone.0050102 3499499
109. Kuksis M Smith PM Ferguson AV: Hydrogen sulfide regulates cardiovascular function by influencing the excitability of subfornical organ neurons. PLoS One. 2014;9(8):e105772. 25144759 10.1371/journal.pone.0105772 4140834
110. Malik R Ferguson AV: Hydrogen sulfide depolarizes neurons in the nucleus of the solitary tract of the rat. Brain Res. 2016;1633:1-9. 26721687 10.1016/j.brainres.2015.12.029
111. Khademullah CS Ferguson AV: Depolarizing actions of hydrogen sulfide on hypothalamic paraventricular nucleus neurons. PLoS One. 2013;8(5):e64495. 23691233 10.1371/journal.pone.0064495 3656899
112. Rodrigo R Libuy M Feliú F: Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers. 2013;35(6):773-90. 24347798 10.1155/2013/974358 3856219
113. Rodrigo R Prat H Passalacqua W: Relationship between oxidative stress and essential hypertension. Hypertens Res. 2007;30(12):1159-67. 18344620 10.1291/hypres.30.1159
114. Cowley AW Jr Yang C Zheleznova NN: Evidence of the Importance of Nox4 in Production of Hypertension in Dahl Salt-Sensitive Rats. Hypertension. 2016;67(2):440-50. 26644237 10.1161/HYPERTENSIONAHA.115.06280 4713301 F1000 Recommendation
115. Dikalova A Clempus R Lassègue B: Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation. 2005;112(17):2668-76. 16230485 10.1161/CIRCULATIONAHA.105.538934
116. Braga VA Colombari E Jovita MG: Angiotensin II-derived reactive oxygen species underpinning the processing of the cardiovascular reflexes in the medulla oblongata. Neurosci Bull. 2011;27(4):269-74. 21788998 10.1007/s12264-011-1529-z
117. Braga VA Medeiros IA Ribeiro TP: Angiotensin-II-induced reactive oxygen species along the SFO-PVN-RVLM pathway: implications in neurogenic hypertension. Braz J Med Biol Res. 2011;44(9):871-6. 21755262 10.1590/S0100-879X2011007500088
118. Kishi T Hirooka Y Kimura Y: Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation. 2004;109(19):2357-62. 15117836 10.1161/01.CIR.0000128695.49900.12 F1000 Recommendation
119. Zimmerman MC Lazartigues E Lang JA: Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res. 2002;91(11):1038-45. 12456490 10.1161/01.RES.0000043501.47934.FA
120. Lob HE Marvar PJ Guzik TJ: Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension. 2010;55(2):277-83, 6p following 283. 20008675 10.1161/HYPERTENSIONAHA.109.142646 2813894 F1000 Recommendation
121. Halaas JL Gajiwala KS Maffei M: Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269(5223):543-6. 7624777 10.1126/science.7624777
122. Carmichael CY Wainford RD: Hypothalamic signaling mechanisms in hypertension. Curr Hypertens Rep. 2015;17(5):39. 25860531 10.1007/s11906-015-0550-4 4392165
123. Stump M Mukohda M Hu C: PPARγ Regulation in Hypertension and Metabolic Syndrome. Curr Hypertens Rep. 2015;17(12):89. 26462805 10.1007/s11906-015-0601-x